Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain

Cell Reports(2021)10.1016/j.celrep.2021.109928Source: DataRank Database

Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 81 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access81 citations

Download PDF

Cite:

Linked data & code

emdb pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.15)OA: goldTopics (19)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Yicheng Guo ORCID,Pengfei Wang ORCID,Manoj S. Nair ORCID,Maple Wang,Yaoxing Huang ORCID

Live enrichment

PubMed:34706271 PMC:PMC8519878 OpenAlex:https://openalex.org/W3206370778

NIAID NIH HHS

Grant: R21 AI144408

NIH HHS

Grant: DP5 OD023118

NIAID NIH HHS

Grant: R21 AI143407

NIH

FWCI

4.15

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.celrep.2021.109928

publisherhttps://doi.org/10.1016/j.celrep.2021.109928

publisherhttps://api.elsevier.com/content/article/PII:S2211124721014017?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124721014017?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34706271

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies

Keywords

NeutralizationAntibodyNeutralizing antibodyBinding siteVirologyChemistryBiologyBiochemistryGeneticsN-terminal domainCryo-emNtdCovid-19Sars-cov-2Variants Of ConcernAntigenic Supersite

Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain

FAIR Checklist

Authors (15)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)